» Articles » PMID: 11748109

Disordered Cellular Migration and Angiogenesis in Cd39-null Mice

Overview
Journal Circulation
Date 2001 Dec 19
PMID 11748109
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nucleoside triphosphate diphosphohydrolase-1 (NTPDase1)/CD39 is the major ectonucleotidase of endothelial cells and monocytes and catalyzes phosphohydrolysis of extracellular nucleoside diphosphates (NDP) and triphosphates (NTP, eg, ATP and UTP). Deletion of cd39 causes perturbations in the hydrolysis of NTP and NDP in the vasculature. Activation of P2 receptors appears to influence endothelial cell chemotactic and mitogenic responses in vitro. Therefore, aberrant regulation of nucleotide P2 receptors may influence angiogenesis in cd39-null mice. Methods and Results- In control mice, implanted Matrigel plugs containing growth factors were rapidly populated by monocyte/macrophages, endothelial cells, and pericytes, with the development of new vessels over days. In cd39-null mice, migrating cells were completely confined to the tissue-Matrigel interface in a clearly stratified manner. Absolute failure of new vessel ingrowth was consistently observed in the mutant mice. Linked to these findings, chemotaxis of cd39-null monocyte/macrophages to nucleotides was impaired in vitro. This abnormality was associated with desensitization of nucleotide receptor P2Y-mediated signaling pathways.

Conclusions: Our findings demonstrate a role for NTPDase1 and phosphohydrolysis of extracellular nucleotides in the regulation of the cellular infiltration and new vessel growth in a model of angiogenesis.

Citing Articles

Impact of Estrogen on Purinergic Signaling in Microvascular Disease.

Cassavaugh J, Longhi M, Robson S Int J Mol Sci. 2025; 26(5).

PMID: 40076726 PMC: 11900469. DOI: 10.3390/ijms26052105.


Advancing Immunotherapy in Pancreatic Cancer.

Hegazi A, Rager L, Watkins D, Su K Int J Mol Sci. 2024; 25(21).

PMID: 39519112 PMC: 11546161. DOI: 10.3390/ijms252111560.


Purinergic Signaling in Non-Parenchymal Liver Cells.

Mata-Martinez E, Ramirez-Ledesma M, Vazquez-Victorio G, Hernandez-Munoz R, Diaz-Munoz M, Vazquez-Cuevas F Int J Mol Sci. 2024; 25(17).

PMID: 39273394 PMC: 11394727. DOI: 10.3390/ijms25179447.


Regulatory role of CD39 and CD73 in tumor immunity.

Kaplinsky N, Williams K, Watkins D, Adams M, Stanbery L, Nemunaitis J Future Oncol. 2024; 20(19):1367-1380.

PMID: 38652041 PMC: 11321403. DOI: 10.2217/fon-2023-0871.


NTPDase1/CD39 Ectonucleotidase Is Necessary for Normal Arterial Diameter Adaptation to Flow.

Favre J, Roy C, Guihot A, Drouin A, Laprise M, Gillis M Int J Mol Sci. 2023; 24(20).

PMID: 37894719 PMC: 10606763. DOI: 10.3390/ijms242015038.